Oppenheimer Downgrades Stereotaxis To Perform

According to Oppenheimer, Stereotaxis STXS rating is downgraded to Perform. Oppenheimer said that it is lowering its rating on STXS to Perform from Outperform and removing its $5 price target. “We lower our '11E/'12E sales by $19M/$18M to 45.2/$62.0M, respectively. Visibility at this point is low. Cost cuts partially offset for '11E/'12E EPS of ($0.61)/($0.31).” Stereotaxis closed yesterday at $2.85.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorDowngradesPrice TargetAnalyst RatingsHealth CareHealth Care EquipmentOppenheimer
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!